Expanding roles of circRNAs in cardiovascular diseases

Liu, Xu; Yao, Xuelin; Chen, Liang

doi:10.1016/j.ncrna.2024.02.001

Non-coding RNA Research

2024

DOI: 10.1016/j.ncrna.2024.02.001

|View full text |Cite

Expanding roles of circRNAs in cardiovascular diseases

Xu Liu,

Xuelin Yao,

Liang Chen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 140 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Correlation between serum levels of circ_0001879 and circ_0004104, coronary microcirculation disorders and prognosis after percutaneous coronary intervention (PCI) in patients with stable coronary heart disease

Zhang,

Zhu,

et al. 2024

International Journal of Cardiology

View full text Add to dashboard Cite

Correlation between serum levels of circ_0001879 and circ_0004104, coronary microcirculation disorders and prognosis after percutaneous coronary intervention (PCI) in patients with stable coronary heart disease

Zhang,

Zhu,

et al. 2024

International Journal of Cardiology

View full text Add to dashboard Cite

Decoding the regulatory roles of circular RNAs in cardiac fibrosis

You,

Yu,

Pan

et al. 2025

Non-coding RNA Research

View full text Add to dashboard Cite

Circular RNAs in coronary heart disease: From molecular mechanism to promising clinical application (Review)

Fan,

Yuan,

Yuan

2024

Int J Mol Med

View full text Add to dashboard Cite

Coronary heart disease (CHD) remains a leading cause of morbidity and mortality worldwide, posing a substantial public health burden. Despite advancements in treatment, the complex etiology of CHD necessitates ongoing exploration of novel diagnostic markers and therapeutic targets. Circular RNAs (circRNAs), a distinct class of non-coding RNAs with a covalently closed loop structure, have emerged as significant regulators in various diseases, including CHD. Their high stability, tissue-specific expression and evolutionary conservation underscore their potential as biomarkers and therapeutic agents in CHD. This review discusses the current knowledge on circRNAs in the context of CHD and explores the molecular mechanisms by which circRNAs influence the pathophysiology of CHD, including cardiomyocyte death, endothelial injury, vascular dysfunction and inflammation. It also summarizes the emerging evidence highlighting the differential expression of circRNAs in patients with CHD and their potential utilities as non-invasive diagnostic and prognostic biomarkers and therapeutic targets for this disease.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Expanding roles of circRNAs in cardiovascular diseases

Cited by 3 publications

References 140 publications

Correlation between serum levels of circ_0001879 and circ_0004104, coronary microcirculation disorders and prognosis after percutaneous coronary intervention (PCI) in patients with stable coronary heart disease

Correlation between serum levels of circ_0001879 and circ_0004104, coronary microcirculation disorders and prognosis after percutaneous coronary intervention (PCI) in patients with stable coronary heart disease

Decoding the regulatory roles of circular RNAs in cardiac fibrosis

Circular RNAs in coronary heart disease: From molecular mechanism to promising clinical application (Review)

Contact Info

Product

Resources

About